NCT03657147 is a NA clinical trial of Educational Video and Question Prompt List in Glaucoma, sponsored by University of North Carolina, Chapel Hill.

Who is sponsoring NCT03657147?

NCT03657147 is sponsored by University of North Carolina, Chapel Hill.

What drugs are being tested in NCT03657147?

Interventions in NCT03657147: Educational Video and Question Prompt List.

Is NCT03657147 still recruiting?

NCT03657147 is currently completed. Last updated 29 June 2023.

Last reviewed 2023-06-29 · How we verify

NCT03657147

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving African American Glaucoma Patient Involvement in Visits and Outcomes

Completed NA Last updated 29 June 2023

What this trial tests

NA trial testing Educational Video and Question Prompt List in Glaucoma in 189 participants. Completed in 12 August 2022.

Timeline

10 September 2018

Primary endpoint
12 August 2022

12 August 2022

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	189
Start date	10 September 2018
Primary completion	12 August 2022
Estimated completion	12 August 2022
Sites	1 location across United States

Drugs / interventions tested

Educational Video and Question Prompt List

Conditions studied

Glaucoma — all drugs for Glaucoma →

Sponsor

University of North Carolina, Chapel Hill

Who can join

18 and older, any sex, with Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a research project about services provided to African American patients with glaucoma. The goal of the project is to improve communication between providers and African-American patients about glaucoma.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Do African American patients with glaucoma ask their eye providers the questions they have?
Beznos B, Sayner R, Carpenter DM, Budenz DL, et al · · 2024 · cited 1× · PMID 37524828 · DOI 10.1038/s41433-023-02674-x
African American patient-provider communication about glaucoma vision quality-of-life.
Sleath B, Beznos B, Carpenter DM, Budenz DL, et al · · 2024 · PMID 37580416 · DOI 10.1038/s41433-023-02693-8

Verify or expand the search:

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03657147 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 29 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03657147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing